Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
The Journal of Infectious Diseases|August 16, 2021
Effect of Rosuvastatin Therapy on Biomarkers of Inflammation and Immune Activation in People With Human Immunodeficiency Virus at Intermediate Cardiovascular RiskAnna C Hearps, Thomas A Angelovich, Janine M Trevillyan, et al.Current Opinion in HIV and AIDS|November 21, 2025
Immunotherapy and impact on tissue reservoirsHannah A D King, Thomas A Angelovich, Michael A Moso, et al.Viruses|September 23, 2022
Non-Human Primate Models of HIV Brain Infection and Cognitive DisordersSarah J Byrnes, Thomas A Angelovich, Kathleen Busman-Sahay, et al.AIDS (London, England)|September 20, 2017
Dysfunctional high-density lipoprotein from HIV+ individuals promotes monocyte-derived foam cell formation in vitroThomas A Angelovich, Anna C Hearps, Michael N Oda, et al.AIDS (London, England)|February 29, 2020
Monocytes from men living with HIV exhibit heightened atherogenic potential despite long-term viral suppression with antiretroviral therapyThomas A Angelovich, Janine M Trevillyan, Jennifer F Hoy, et al.Atherosclerosis|February 8, 2026
Circulating monocytes pre-disposed to form atherogenic foam cells are characterised by distinct transcriptional changes in people with HIVAnna C Hearps, Jennifer Boer, Morgane Brunton-O'Sullivan, et al.Biomolecules|December 30, 2025
HCMV as an Oncomodulatory Virus in Ovarian Cancer: Implications of Viral Strain Heterogeneity, Immunomodulation, and Inflammation on the Tumour Microenvironment and Ovarian Cancer ProgressionChrissie Giatrakis, Apriliana E R Kartikasari, Thomas A Angelovich, et al.Aging Cell|June 20, 2012
Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and functionAnna C Hearps, Genevieve E Martin, Thomas A Angelovich, et al.Journal of Virus Eradication|July 13, 2023
Adaptation of the intact proviral DNA assay to a nanowell-based digital PCR platformCarolin Tumpach, Catherine R Cochrane, Youry Kim, et al.Frontiers in Immunology|July 18, 2017
Persistence of Activated and Adaptive-Like NK Cells in HIV<sup>+</sup> Individuals despite 2 Years of Suppressive Combination Antiretroviral TherapyAnna C Hearps, Paul A Agius, Jingling Zhou, et al.Pageof 4